SUDARSCHEM Sudarshan Chemical Industries Q1 FY26 results (Apr–Jun 2025) and concall
Sudarshan Chemical Industries reported a mixed Q1 FY26, with total revenue reaching INR 2,507 crores, driven significantly by the newly acquired Heubach and Clariant businesses. While legacy Sudarshan saw a marginal revenue decline, its EBITDA margin improved to 13.9%. The acquired group contributed INR 1,882 crores in revenue, and management expressed confidence in achieving EUR 35 million EBITDA from this segment this year, targeting EUR 90-100 million by FY28/29 despite current market headwinds and high customer inventories.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 696 | 666 | 1,349 | 2,507 |
| EBITDA | 94 | 79 | 127 | 192 |
| Net profit | 30 | 1 | 0 | 55 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
